≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

EFO Endpoint Browser PheWeb

P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — P00-P04
  • Cause of death: ICD-10 — P00-P04

2 out of 7 registries used, show all original rules.

506

4. Check minimum number of events

None

506

5. Include endpoints

506

6. Filter based on genotype QC (FinnGen only)

506

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P
Name in latin
Fetus et neonatus factoribus maternis atque complicationibus graviditatis, laborum et partus affectus

Similar endpoints

↥

List of similar endpoints to Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 43198 19780 23410
Only index persons 16855 7854 9001
Unadjusted period prevalence (%)
Whole population 0.61 0.57 0.65
Only index persons 0.32 0.29 0.34
Median age at first event (years)
Whole population 0.01 0.00 0.00
Only index persons 0.00 0.00 0.00

-FinnGen-

Key figures

All Female Male
Number of individuals 506 277 229
Unadjusted period prevalence (%) 0.10 0.09 0.10
Median age at first event (years) 0.00 0.00 0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
443
Matched controls
4344
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P07.3
ICD-10 Finland
Other preterm infants
24.5
122.5
183
121
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
+∞
98.0
91
*
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
+∞
96.9
90
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
+∞
82.4
77
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
13.9
78.2
145
147
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
+∞
41.0
39
*
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
23.2
28.5
41
19
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
13.4
26.7
47
38
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
8.5
25.3
57
74
P00.8
ICD-10 Finland
Fetus and newborn affected by other maternal conditions
+∞
22.9
22
*
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
+∞
20.8
20
*
WX722
NOMESCO Finland
PEEP
6.3
20.7
57
99
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
9.4
20.6
43
49
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
12.4
18.4
33
28
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.1
17.5
73
200
P05.1
ICD-10 Finland
Small for gestational age
10.5
17.0
33
33
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
6.2
16.4
45
78
P05.0
ICD-10 Finland
Light for gestational age
15.8
16.2
26
17
P07.1
ICD-10 Finland
Other low birth weight
30.8
16.1
21
7
P07.2
ICD-10 Finland
Extreme immaturity
17.9
13.8
21
12
P02.7
ICD-10 Finland
Fetus and newborn affected by chorioamnionitis
+∞
13.5
13
*
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
22.9
12.9
18
8
P03.0
ICD-10 Finland
Fetus and newborn affected by breech delivery and extraction
+∞
12.5
12
*
P00.2
ICD-10 Finland
Fetus and newborn affected by maternal infectious and parasitic diseases
+∞
12.5
12
*
P03.3
ICD-10 Finland
Fetus and newborn affected by delivery by vacuum extractor [ventouse]
+∞
12.5
12
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
9.9
12.2
24
25
P04.1
ICD-10 Finland
Fetus and newborn affected by other maternal medication
+∞
11.4
11
*
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
6.5
11.4
29
46
602
Kela drug reimbursment
Children's severe malnutrition
3.7
11.3
51
149
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
16.9
9.8
15
9
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
11.5
9.5
17
15
H35.1
ICD-10 Finland
Retinopathy of prematurity
17.7
9.4
14
8
P04.4
ICD-10 Finland
Fetus and newborn affected by maternal use of drugs of addiction
+∞
9.3
9
*
P03.1
ICD-10 Finland
Fetus and newborn affected by other malpresentation, malposition and disproportion during labour and delivery
+∞
9.3
9
*
A11JC
ATC
Vitamins, other combinations
14.1
8.6
14
10
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
8.5
92
459
P04.2
ICD-10 Finland
Fetus and newborn affected by maternal use of tobacco
+∞
8.3
8
*
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
8.6
8.3
17
20
WX882
NOMESCO Finland
High dependency care
2.2
8.0
82
400
P22.8
ICD-10 Finland
Other respiratory distress of newborn
8.5
7.8
16
19
R4110
NOMESCO Finland
Physiotherapy
1.9
7.5
129
769
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
5.1
7.4
22
44
P01.11
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes more than 7 days before delivery
+∞
7.3
7
*
P21.0
ICD-10 Finland
Severe birth asphyxia
11.0
6.2
11
10
Z2446
NOMESCO Finland
Social worker
1.9
6.2
107
636
P02.6
ICD-10 Finland
Fetus and newborn affected by other and unspecified conditions of umbilical cord
+∞
6.2
6
*
RK312
NOMESCO Finland
NA
7.0
6.2
14
20
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
4.5
6.1
20
45

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
13
26
5.04
6.15
1.0
1.0
g/l
162.8
163.2
0.01
13
26
(3022670) pH of Venous cord blood
18
55
3.32
4.97
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
40
3.01
2.92
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
193
1.79
2.52
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
193
1.79
2.52
1.9
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
57
2.47
2.41
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
53
2.46
2.23
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
72
2.23
2.23
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
139
1120
1.31
1.94
15.9
12.0
mmol/l
0.8
0.8
0.08
101
812
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
72
2.09
1.82
1.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
234
2033
1.26
1.76
5.0
5.6
u/l
154.6
135.4
1.98
228
1903
(3008898) HLA-B27 [Presence]
9
192
0.45
1.76
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
304
1.51
1.76
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
124
1002
1.30
1.68
16.2
11.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
105
837
1.30
1.58
4.2
4.3
e6/l
2.1
2.4
0.22
66
484
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
106
1.80
1.55
1.2
1.3
ug/g
446.0
385.4
—
8
57
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.2
—
18.7
—
0
11
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.2
—
30.6
—
0
8
(3048689) Calprotectin [Mass/mass] in Stool
68
867
0.74
1.52
2.1
3.1
ug/g
62.7
89.0
0.84
55
699
(3032080) INR in Blood by Coagulation assay
61
790
0.73
1.51
3.1
5.1
inr
1.1
1.1
0.38
18
193
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
267
1.48
1.46
1.7
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
120
986
1.27
1.42
11.3
13.4
mmol/l
1.5
1.4
2.20
114
945
(3002582) Erythrocytes [#/volume] in Urine
159
1350
1.24
1.42
5.3
5.2
e6/l
15.1
23.4
0.95
117
1012
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
377
0.64
1.40
1.2
1.2
u/ml
1.1
7.0
—
7
106
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
1399
1.23
1.40
6.2
5.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
8
163
0.48
1.37
2.5
3.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
151
1279
1.24
1.37
5.1
4.9
e6/l
0.2
0.2
0.06
109
946
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
157
1.60
1.37
1.8
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
873
1.27
1.34
3.1
2.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
145
0.47
1.34
2.0
5.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
126
1050
1.25
1.32
16.4
11.9
kpa
9.4
9.7
1.08
120
1016
(3037522) Nuclear Ab [Titer] in Serum
37
508
0.70
1.31
1.7
1.6
titre
293.3
524.2
—
6
76
(3013826) Glucose [Moles/volume] in Serum or Plasma
234
2080
1.21
1.31
7.8
9.3
mmol/l
6.0
5.9
0.12
220
1946
(3022217) INR in Platelet poor plasma by Coagulation assay
16
90
1.78
1.30
1.5
12.0
inr
1.0
1.4
—
7
18
(4306422)
12
61
1.97
1.29
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
189
0.51
1.29
1.7
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
606
0.72
1.28
2.3
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
390
0.67
1.25
1.2
1.2
iu/ml
13.8
18.1
—
7
89
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
222
1971
1.20
1.24
15.9
15.5
mmol/l
1.2
1.2
0.02
206
1848
(3002256) Pathology report gross observation
16
260
0.60
1.24
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
166
0.53
1.21
2.3
3.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
9
168
0.52
1.20
2.3
3.7
%
16.1
9.1
—
9
158
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
100
821
1.25
1.20
4.4
4.2
e6/l
0.6
0.9
1.16
62
467
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
139
1.59
1.20
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
49
2.04
1.19
1.2
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
40
291
1.39
1.13
2.2
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
106
883
1.24
1.12
2.6
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
120
1013
1.22
1.12
2.6
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
39
514
0.73
1.10
2.3
4.6
g/l
8.7
8.5
0.16
39
497
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
163
0.54
1.10
2.9
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
179
1573
1.19
1.10
6.7
6.0
e6/l
54.8
56.4
0.02
122
1051
(36304419) Bacteria [Presence] in Urine
149
1288
1.20
1.09
5.0
4.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
21
2.37
1.07
1.2
8.4
%
45.1
38.0
—
5
21
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
46
1.95
1.03
1.6
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
108
0.45
1.01
9.8
27.5
%
11.1
11.4
—
5
108
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
170
0.57
0.95
1.5
5.0
mmol/l
3.6
3.2
—
10
163
(1761482) Bacteria [#/volume] in Urine by Culture
7
37
1.88
0.93
1.9
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
28
2.13
0.91
1.3
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1924
1.16
0.91
16.6
16.8
mmol/l
1.2
1.2
0.47
204
1846
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
117
1.54
0.90
5.9
5.9
ug/l
2.2
2.5
0.27
18
117
(3026782) Osmolality of Urine
102
866
1.21
0.90
3.7
3.9
mosm/kgh2o
576.4
595.6
0.27
77
752
(3000850) Epithelial cells [#/volume] in Urine
103
879
1.20
0.87
4.3
4.1
e6/l
6.0
6.7
0.27
80
775
(3016018) Differential panel - Cerebral spinal fluid
6
114
0.51
0.83
1.7
4.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
114
0.51
0.83
1.8
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
35
264
1.33
0.83
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
35
264
1.33
0.83
1.0
1.0
mmol/l
-3.6
-2.3
—
9
68
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
35
264
1.33
0.83
1.0
1.0
kpa
7.6
7.2
0.41
26
221
(3023368) Bacteria identified in Blood by Culture
82
688
1.21
0.83
3.9
4.6
—
—
—
0
0
(3019225) pH of Specimen
18
120
1.50
0.82
8.7
5.9
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
121
1.49
0.80
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
121
1.49
0.80
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
121
1.49
0.80
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
121
1.49
0.80
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
252
0.69
0.76
4.3
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
98
1.53
0.75
1.6
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
9
53
1.69
0.75
1.0
1.1
%
84.0
91.0
—
9
53
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
24
2.07
0.74
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
115
1.48
0.74
2.1
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
194
1764
1.14
0.73
3.7
3.2
mmol/mol
35.6
36.1
0.20
181
1657
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
75
1.59
0.72
2.2
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
221
2028
1.14
0.72
2.1
2.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
34
262
1.30
0.71
1.0
1.0
kpa
2.7
3.4
2.44
25
219
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
143
1275
1.15
0.71
6.0
10.1
umol/l
41.1
29.0
1.41
130
1164
(3019230) Fractional oxyhemoglobin in Venous blood
9
143
0.61
0.70
6.7
22.9
%
71.1
72.2
—
9
143
(40768797) Stomach Pathology biopsy report
20
270
0.72
0.70
1.3
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
26
1.91
0.70
1.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
32
402
0.77
0.70
1.5
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
42
1.66
0.68
5.1
8.6
%
1.4
1.4
—
7
37
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
614
1.18
0.63
10.9
16.3
mmol/l
0.8
0.8
0.13
66
595
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
187
1988
0.89
0.63
3.0
3.0
mmol/l
4.3
4.3
0.09
177
1886
(3015377) Calcium [Moles/volume] in Serum or Plasma
102
896
1.16
0.63
3.3
3.1
mmol/l
2.4
2.4
0.49
95
819
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
341
0.77
0.62
1.4
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
95
1.47
0.61
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
95
1.47
0.61
1.5
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
136
0.65
0.61
2.9
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
30
1.65
0.60
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
155
1.35
0.60
2.0
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
103.9
—
0
22
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
148
0.66
0.58
3.2
6.2
%
108.2
94.5
—
10
148
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
148
0.66
0.58
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
88
1.47
0.58
6.8
7.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
182
1930
0.89
0.58
2.9
2.8
mmol/l
1.4
1.4
0.02
170
1816
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
89
1.45
0.55
2.2
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
29
228
1.27
0.55
7.7
6.4
%
0.1
0.0
0.47
14
78
(3024980) IgG subclass 4 [Mass/volume] in Serum
8
120
0.65
0.55
1.9
1.5
g/l
1.0
0.7
—
8
102
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
46
537
0.83
0.55
1.2
1.2
—
72.8
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
132
1.36
0.54
1.4
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
39
462
0.82
0.54
1.5
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
536
0.83
0.54
2.0
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
145
0.67
0.54
6.2
22.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
38
1.57
0.54
1.7
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
217
2018
1.11
0.53
7.6
11.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
42
348
1.21
0.52
1.0
1.0
mu/l
9.2
8.6
0.13
35
301
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
64
1.40
0.51
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
42
490
0.83
0.51
1.5
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
83
1.44
0.49
1.1
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
164
0.72
0.48
1.8
5.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
278
1.22
0.48
10.1
8.9
g/l
0.3
0.3
0.18
28
233
(3018418) pH of Serum or Plasma
87
772
1.14
0.48
4.4
4.2
ph
7.4
7.4
0.14
12
126
(3002179) Metamyelocytes/100 leukocytes in Blood
28
224
1.25
0.48
7.4
5.5
%
0.8
0.3
—
10
62
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
160
1692
0.90
0.47
3.6
5.2
u/l
24.7
26.9
0.45
153
1625
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
757
0.87
0.47
2.1
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
46
528
0.85
0.47
5.8
9.1
umol/l
4.8
6.4
0.97
34
435
(3015736) pH of Urine
139
1271
1.11
0.47
4.1
3.5
—
—
—
0
0
(3020891) Body temperature
5
80
0.61
0.46
15.8
9.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
91
991
0.89
0.46
3.9
6.0
u/l
32.8
35.2
0.36
84
949
(3045414) Leukocytes [Presence] in Urine
17
128
1.32
0.45
1.5
1.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
10
68
1.46
0.45
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
25
303
0.81
0.44
1.8
2.5
u/l
21.8
30.4
1.63
20
245
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
186
1946
0.91
0.44
3.0
2.8
mmol/l
2.6
2.6
0.48
175
1820
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
183
0.75
0.44
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
125
0.71
0.44
3.8
2.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
323
0.82
0.43
2.6
2.2
u/ml
235.1
167.9
0.46
15
149
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
237
0.78
0.43
1.1
1.2
u/ml
18.6
11.1
0.34
11
143
(40768804) Tissue Pathology biopsy report
68
751
0.88
0.43
1.8
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
98
1058
0.89
0.43
3.1
2.6
—
—
—
0
0
(4035726)
17
215
0.77
0.43
1.8
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
171
1588
1.10
0.42
4.2
3.8
estimate
0.0
0.0
0.00
16
264
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
258
0.80
0.42
1.0
1.1
u/ml
11.6
8.2
0.22
11
150
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
165
1.27
0.42
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
32
1.55
0.42
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
58
1.37
0.41
6.4
4.9
ug/l
28.0
25.6
—
8
58
(3009261) Glucose [Presence] in Urine by Test strip
171
1591
1.09
0.41
4.2
3.8
estimate
0.0
0.0
0.00
23
276
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
60
1.32
0.40
2.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
17
131
1.29
0.39
1.7
2.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
18
223
0.79
0.39
1.0
1.1
u/ml
0.0
0.5
—
7
109
(4010399)
24
194
1.23
0.39
1.4
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
393
3966
0.91
0.39
12.5
12.0
mg/l
21.0
23.5
0.80
282
2672
(3003327) Ova and parasites identified in Stool by Light microscopy
24
287
0.82
0.39
1.8
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
497
0.86
0.38
1.4
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
29
240
1.21
0.38
7.7
6.3
%
1.3
0.4
0.82
14
84
(3020874) Milk IgE Ab [Units/volume] in Serum
17
211
0.79
0.38
1.6
1.6
u/ml
3.2
4.1
0.13
12
157
(40768446) Kidney Pathology biopsy report
9
67
1.33
0.38
2.4
2.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
243
2302
1.08
0.37
5.7
4.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
40
454
0.86
0.37
2.6
4.1
ng/l
2516.1
1223.1
0.37
23
266
(3020630) Protein [Mass/volume] in Serum or Plasma
12
156
0.75
0.37
2.9
4.0
g/l
61.1
63.0
0.27
12
149
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
68
1.31
0.37
8.2
10.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
327
0.84
0.36
2.5
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
155
0.76
0.36
1.4
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
260
2473
1.08
0.36
7.6
10.7
%
8.4
8.3
0.03
250
2368
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
175
1821
0.92
0.36
1.8
1.8
u/ml
2.3
4.1
1.03
30
302
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
28
233
1.20
0.36
2.3
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
169
1581
1.08
0.35
6.3
5.6
estimate
0.0
0.0
0.00
23
281
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
42
1.42
0.35
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
280
2673
1.08
0.35
8.7
12.4
e9/l
3.3
3.5
0.42
226
2194
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
43
1.38
0.35
1.0
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
373
1.15
0.34
3.2
2.4
u/l
740.8
5537.6
—
10
97
(3000764) Benzodiazepines [Presence] in Urine
44
492
0.87
0.34
1.4
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
152
1.24
0.34
2.2
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
271
2585
1.08
0.34
8.0
11.4
e9/l
0.2
0.2
2.50
226
2171
(3021960) Folate [Moles/volume] in Serum or Plasma
49
430
1.14
0.34
1.6
1.4
nmol/l
23.9
20.6
0.78
42
373
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
419
4207
0.91
0.33
4.1
3.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
45
1.32
0.33
1.3
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
131
0.75
0.33
1.4
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
85
0.69
0.33
4.3
2.8
umol/l
14.8
14.8
—
6
85
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
332
3194
1.08
0.33
4.0
3.7
mu/l
2.1
2.0
0.70
308
2999
(3035320) C reactive protein [Mass/volume] in Body fluid
6
46
1.29
0.32
1.8
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
195
0.80
0.32
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
64
575
1.11
0.31
2.1
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
25
209
1.19
0.31
3.4
3.0
pmol/l
5.3
5.1
0.38
25
190
(3028300) Cannabinoids [Presence] in Urine
45
497
0.88
0.30
1.4
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
162
1523
1.07
0.30
4.2
4.0
nmol/l
71.7
68.3
0.84
156
1445
(3014051) Protein [Presence] in Urine by Test strip
11
83
1.32
0.30
1.5
1.7
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
55
1.26
0.29
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
162
1524
1.07
0.29
6.8
10.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
168
1738
0.93
0.29
1.7
1.7
g/l
1.5
1.4
0.42
73
867
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
106
0.74
0.29
1.5
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
56
1.24
0.29
1.0
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
56
1.24
0.29
11.1
8.4
—
—
—
0
0
(3044889) 12 lead EKG panel
147
1379
1.07
0.29
2.3
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
297
2854
1.07
0.29
3.6
3.3
pmol/l
14.5
14.4
0.12
270
2583
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
202
1.18
0.28
2.0
2.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
192
0.82
0.28
1.7
1.4
g/l
0.2
0.2
0.04
16
185
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
117
0.76
0.27
1.6
4.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
64
1.24
0.27
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
72
0.68
0.26
1.8
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
167
1.19
0.26
2.1
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
348
3506
0.94
0.25
15.9
15.2
mmol/l
139.2
139.3
0.47
339
3400
(3025159) Blasts/100 leukocytes in Blood
26
223
1.16
0.25
8.2
6.3
%
0.0
0.1
0.49
11
68
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
73
1.22
0.25
1.1
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
74
1.21
0.25
2.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
261
1.14
0.25
1.7
2.1
nmol/l
8.3
8.6
0.06
22
198
(40761535) Cells panel - Urine sediment
12
146
0.81
0.24
13.3
4.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
76
1.17
0.24
2.2
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
22
187
1.17
0.24
9.2
11.9
mmol/l
22.3
23.0
0.80
22
173
(3013336) Amino acids [Identifier] in Serum or Plasma
6
83
0.71
0.24
1.5
2.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
84
0.70
0.24
5.3
5.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
37
328
1.12
0.24
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
455
4537
0.91
0.23
17.1
17.7
e9/l
7.2
7.1
0.16
433
4276
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32
282
1.13
0.22
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
12
96
1.24
0.22
1.8
4.1
ug/l
212.4
324.4
0.37
12
87
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
983
1.07
0.22
4.1
3.5
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
7
93
0.74
0.22
1.1
1.8
ng/l
165.6
138.5
—
7
88
(3011288) Drugs identified in Urine by Screen method
30
332
0.89
0.22
1.8
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
251
2414
1.05
0.22
7.8
10.7
%
0.6
0.6
0.22
245
2319
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
109
1023
1.07
0.22
6.4
11.3
mmol/l
23.3
23.6
0.60
102
996
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
217
1.15
0.22
1.1
1.1
—
33.8
—
0
7
(3025941) Bacteria identified in Stool by Culture
16
186
0.84
0.22
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
124
1.20
0.22
2.3
1.3
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
6.1
1.4
—
5
34
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
3.5
3.0
—
5
34
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
0.9
1.1
—
5
32
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
1.1
5.8
—
5
31
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
2.0
1.4
—
5
30
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
0.4
1.1
—
5
34
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
5
41
1.21
0.22
1.6
1.9
mg/l
1.1
1.1
—
5
36
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
1.5
—
0
10
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.2
—
35.1
—
0
10
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
11
0.00
0.21
0.0
18.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
18.5
—
26.9
—
0
11
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
181
1850
0.95
0.21
6.9
6.2
ml/min/173m2
113.2
111.7
0.31
119
1121
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
42
1.18
0.21
2.0
1.6
pmol/l
168.8
694.7
—
5
33
(21494814) CD8 cells/100 lymphocytes in Specimen
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
12
0.00
0.21
0.0
4.2
—
14.3
—
0
12
(3000963) Hemoglobin [Mass/volume] in Blood
455
4534
0.91
0.21
17.3
18.1
g/l
132.9
131.7
1.08
448
4462
(3022229) Phosphate [Moles/volume] in Urine
12
97
1.23
0.21
2.9
3.3
mmol/l
21.9
20.1
0.17
12
89
(40765096) Chromosome analysis panel by Banding
0
13
0.00
0.20
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
0
13
0.00
0.20
0.0
12.2
—
13.6
—
0
13
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
162
1.16
0.20
3.1
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
132
0.82
0.20
1.5
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
255
2458
1.05
0.20
7.7
10.6
%
2.8
3.3
3.76
248
2352
(3036603) Volume of Urine
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
245
2481
0.95
0.20
4.1
4.6
mm/h
6.3
7.3
1.73
230
2310
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
45
409
1.10
0.19
11.9
9.7
ng/l
59.9
50.1
0.54
45
404
(3004119) Hemoglobin [Mass/volume] in Venous blood
21
236
0.87
0.19
7.5
18.3
g/l
124.5
125.3
0.06
21
231
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
50
1.19
0.19
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
52
1.14
0.19
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
145
1.16
0.18
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
136
1293
1.05
0.18
1.8
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
193
0.87
0.18
1.6
1.4
g/l
1.2
1.1
0.42
17
185
(3026361) Erythrocytes [#/volume] in Blood
455
4530
0.92
0.18
17.1
17.6
e12/l
4.6
4.6
0.98
434
4261
(3009466) Valproate [Moles/volume] in Serum or Plasma
12
99
1.20
0.18
5.3
4.7
umol/l
475.1
439.7
0.28
12
93
(3019060) Gas panel - Arterial blood
7
60
1.15
0.17
3.7
4.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
181
1841
0.96
0.17
2.8
2.9
mmol/l
1.1
1.1
0.36
170
1738
(3035941) MCH [Entitic mass]
455
4529
0.92
0.17
17.0
17.6
pg
28.8
28.7
0.23
447
4455
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
61
1.14
0.17
1.3
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
349
3498
0.95
0.17
15.8
15.1
mmol/l
4.0
4.0
3.03
339
3372
(3000492) Spirometry study
28
250
1.11
0.17
1.6
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
57
528
1.07
0.17
18.6
22.1
mg/l
1.1
1.1
0.16
57
522
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
66
0.75
0.17
1.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
165
1.14
0.17
2.1
2.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
455
4528
0.93
0.16
17.0
17.6
fl
85.5
85.5
0.04
447
4451
(3023511) Choriogonadotropin [Units/volume] in Urine
20
222
0.89
0.16
1.5
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
260
2517
1.04
0.16
7.7
10.4
e9/l
0.0
0.0
0.27
212
2057
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
57
598
0.93
0.16
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
76
0.78
0.15
3.2
2.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
242
1.11
0.15
2.0
2.1
—
16.2
—
0
14
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
999
0.95
0.15
2.8
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
204
1967
1.04
0.15
3.6
3.6
ug/l
43.3
48.7
0.55
195
1868
(3007461) Platelets [#/volume] in Blood
455
4526
0.93
0.15
17.1
17.7
e9/l
278.7
275.0
0.53
434
4274
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
113
1075
1.05
0.15
2.5
3.5
mg/l
2.5
2.7
0.34
96
973
(40768443) Skin Pathology biopsy report
9
81
1.10
0.15
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
576
0.94
0.15
2.2
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
27
243
1.10
0.14
1.6
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
86
0.80
0.14
2.4
2.3
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
11
92
1.19
0.14
1.3
1.3
u/ml
16.9
15.1
0.04
11
86
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
65
675
0.94
0.14
1.7
3.2
u/l
57.4
55.6
0.12
59
629
(3027135) IgG subclass 1 [Mass/volume] in Serum
8
95
0.83
0.14
1.4
1.3
g/l
6.4
5.9
—
8
81
(3028192) IgG subclass 2 [Mass/volume] in Serum
8
95
0.83
0.14
1.4
1.3
g/l
2.3
2.0
—
8
82
(3024139) IgG subclass 3 [Mass/volume] in Serum
8
95
0.83
0.14
1.4
1.3
g/l
0.2
0.4
—
8
80
(3021589) Normoblasts [#/volume] in Blood
248
2405
1.04
0.13
9.3
12.2
e9/l
0.0
0.0
0.56
182
1793
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
361
3525
1.04
0.13
7.5
9.6
u/l
25.5
24.9
0.10
347
3396
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
213
2060
1.04
0.13
2.3
2.2
mmol/l
5.2
5.3
0.69
191
1870
(3001604) Monocytes [#/volume] in Blood
259
2514
1.04
0.13
7.7
10.4
e9/l
0.6
0.6
0.67
212
2056
(3042936) Bacteria identified in Isolate by Culture
40
422
0.93
0.13
2.2
1.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
126
0.86
0.13
1.1
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
25
226
1.10
0.13
10.2
16.7
mmol/l
-1.4
-0.0
0.94
20
181
(3018010) Neutrophils/100 leukocytes in Blood
260
2526
1.03
0.13
7.4
10.2
%
46.5
47.9
0.98
253
2432
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
150
1.12
0.12
10.0
21.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
236
1.09
0.12
1.7
1.8
—
—
—
0
0
(44813793)
10
84
1.18
0.12
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
74
762
0.95
0.12
3.7
3.2
kg/l
1.0
1.0
0.01
23
146
(3003694) ABO and Rh group [Type] in Blood
123
1251
0.96
0.12
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
450
0.94
0.12
1.2
1.3
u/ml
1.5
3.3
0.63
30
304
(3002385) Erythrocyte distribution width [Ratio]
392
3906
0.96
0.11
16.6
17.4
%
13.3
13.2
1.18
384
3839
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
11
94
1.16
0.11
1.3
1.2
u/ml
7.9
7.1
0.05
11
87
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
196
0.90
0.11
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
199
1.10
0.11
2.1
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
547
1.05
0.11
2.8
2.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
124
0.87
0.11
1.7
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
108
1098
0.96
0.10
6.6
10.5
%
83.9
84.2
0.04
108
1089
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
200
1.09
0.10
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
45
1.10
0.09
2.4
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
5
46
1.07
0.09
5.4
4.3
mmol/l
2.0
1.7
—
5
46
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
47
1.05
0.09
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
356
1.06
0.09
2.2
2.3
u/l
6.6
5.5
0.35
23
217
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
96
1.13
0.08
2.2
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
415
0.95
0.08
1.2
1.2
u/ml
0.4
4.5
4.71
11
140
(3026389) Candida sp identified in Specimen by Organism specific culture
6
55
1.08
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
173
0.91
0.08
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
56
1.06
0.08
2.2
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
69
705
0.96
0.08
2.3
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
264
2578
1.02
0.08
7.6
10.3
%
37.9
36.5
1.06
257
2480
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
64
1.08
0.08
1.0
1.3
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
67
1.03
0.08
8.9
6.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
67
1.03
0.08
7.3
6.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
172
0.92
0.08
1.3
1.3
—
—
—
0
0
(4198724)
6
70
0.84
0.07
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
329
1.05
0.07
2.3
2.3
iu/l
7.3
6.4
0.15
23
211
(3052851) Hemolysis interference index of Serum or Plasma
17
155
1.09
0.07
2.9
3.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
161
0.92
0.07
1.1
3.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
44
452
0.96
0.07
8.5
17.6
mmol/l
1.6
1.3
0.84
38
407
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
136
1.09
0.07
1.5
1.3
—
—
—
0
0
(44790049)
18
165
1.08
0.07
1.9
2.3
—
—
—
0
0
(44790048)
18
165
1.08
0.07
1.9
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
165
1.08
0.07
2.2
1.9
—
—
—
0
0
(44790047)
18
165
1.08
0.07
1.9
2.3
—
—
—
0
0
(44806118)
18
165
1.08
0.07
1.9
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
262
1.06
0.07
3.9
4.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
89
0.89
0.07
1.8
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
92
0.86
0.07
2.3
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
48
457
1.04
0.06
3.1
5.9
e9/l
58.4
62.2
0.24
31
288
(4062490)
8
94
0.84
0.06
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
350
1.05
0.06
2.5
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
65
624
1.03
0.06
2.8
6.3
mg/l
1.4
2.2
1.05
43
450
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
127
1.09
0.06
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
416
4129
0.97
0.06
14.7
16.9
%
39.4
38.9
1.74
374
3711
(3000991) Gas panel - Venous blood
101
978
1.03
0.06
9.3
13.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
46
439
1.04
0.06
2.7
2.3
ng/l
56.4
45.4
0.09
23
163
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
13
118
1.09
0.05
3.7
5.0
umol/l
23.8
24.0
0.04
13
118
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
103
1036
0.98
0.05
3.8
3.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
352
1.04
0.05
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
157
1.07
0.05
1.2
1.4
miu/ml
144.7
259.1
—
6
71
(40761511) CBC panel - Blood by Automated count
396
3894
1.02
0.05
9.7
8.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
99
1.10
0.05
5.8
4.3
%
47.0
48.5
0.14
11
99
(3019198) Lymphocytes [#/volume] in Blood
260
2587
0.99
0.04
7.7
10.3
e9/l
2.7
2.5
1.37
218
2191
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
218
0.95
0.04
2.9
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
178
0.94
0.04
2.3
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
137
1337
1.02
0.04
3.8
4.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
129
1.07
0.04
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
77
774
0.98
0.03
5.5
5.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
67
650
1.02
0.03
2.0
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
29
277
1.04
0.03
1.3
1.4
pmol/l
551.3
26693694.3
0.50
23
251
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
445
0.97
0.03
2.9
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
445
0.97
0.03
3.0
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
75
730
1.02
0.02
3.7
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
73
732
0.98
0.02
1.9
1.6
pmol/l
102.0
97.8
0.28
33
384
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
209
1.04
0.02
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
111
1.07
0.02
1.9
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
180
1.04
0.02
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
105
1047
0.99
0.02
2.5
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
82
801
1.01
0.02
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
107
1048
1.01
0.01
7.5
12.1
kpa
5.2
5.3
0.12
102
1025
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
274
0.97
0.01
2.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
59
575
1.02
0.01
2.1
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
112
1.06
0.01
7.8
9.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
234
0.97
0.01
1.8
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
78
764
1.01
0.00
4.4
3.9
estimate
0.0
0.0
0.00
20
266
(3050129) First trimester maternal screen panel - Serum or Plasma
18
181
0.98
0.00
1.6
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
104
1.05
0.00
1.2
1.6
ug/l
11.4
5.0
0.48
11
96
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
96
1.03
0.00
6.1
3.7
e9/l
3.4
3.1
—
10
96
(3013512) EKG study
39
387
1.00
0.00
2.7
2.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
142
0.97
0.00
1.8
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
42
419
0.99
0.00
1.1
1.2
u/ml
0.7
0.9
0.14
29
310
(3003888) Timothy IgE Ab [Units/volume] in Serum
43
427
0.99
0.00
1.1
1.2
u/ml
4.7
5.6
0.14
32
329
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
348
0.99
0.00
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
123
1.05
0.00
1.0
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
17
167
1.01
0.00
12.9
21.1
%
0.7
0.8
0.30
17
167
(3002032) Base excess in Venous blood by calculation
109
1080
1.00
0.00
7.7
12.3
mmol/l
0.6
1.0
0.59
90
836
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
95
1.04
0.00
1.7
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
109
1.00
0.00
14.5
6.1
u/ml
36.4
30.4
0.10
11
104
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
131
0.98
0.00
2.1
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
109
1082
0.99
0.00
7.6
12.2
kpa
5.7
5.7
0.54
104
1058
(3014007) Fractional oxyhemoglobin in Arterial blood
17
165
1.02
0.00
13.2
21.3
%
94.4
95.7
0.17
17
165
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
350
0.99
0.00
1.4
1.3
iu/ml
218.4
143.9
—
10
107
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.1
—
1.9
—
0
9
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
403.3
—
0
9
(3013290) Carbon dioxide [Partial pressure] in Blood
7
69
1.00
0.00
8.0
10.5
kpa
5.2
4.9
—
7
69
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
82
0.96
0.00
3.4
2.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
69
1.00
0.00
8.1
9.9
kpa
9.5
9.1
—
7
69
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
54
0.91
0.00
1.2
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
77
0.90
0.00
4.1
5.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
69
0.86
0.00
1.0
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
78
0.89
0.00
1.0
1.2
—
0.2
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
87
0.91
0.00
4.0
4.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
80
0.99
0.00
2.0
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
98
0.91
0.00
1.4
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
51
0.97
0.00
1.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
85
0.93
0.00
1.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
14.3
—
0
6
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
93
0.96
0.00
1.4
1.2
%
63.8
75.8
—
9
93
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
5.9
—
3.9
—
0
8
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
25.6
—
0
7
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
75.1
—
0
6
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
87
0.91
0.00
2.1
2.8
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
78
0.89
0.00
1.0
1.2
—
33.5
—
0
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
93
0.96
0.00
1.4
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
83
0.95
0.00
1.6
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.2
—
980.4
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
17.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
52
0.95
-0.00
1.4
2.0
%
82.6
124.1
—
5
52

Mortality – FinRegistry

↥

Association

Association between endpoint P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV and mortality.

Females

Parameter HR [95% CI] p-value
P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV 1.511 [1.16, 1.97] 0.002
Birth year 0.998 [0.99, 1.01] 0.664

During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 18172 females with P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV died.

Males

Parameter HR [95% CI] p-value
P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV 1.458 [1.19, 1.79] < 0.001
Birth year 0.991 [0.98, 1.0] 0.065

During the follow-up period (1.1.1998 — 31.12.2019), 107 out of 21554 males with P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV died.

Mortality risk

Mortality risk for people of age

years, who have P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV.

N-year risk Females Males
1 0.105% 0.363%
5 0.922% 1.99%
10 2.39% 4.812%
15 4.726% 9.086%
20 8.271% 14.988%

Relationships between endpoints

↥

Index endpoint: P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV – Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data